Arkema Appoints Hubron as Distributor of Graphistrength Multiwall Carbon Nanotube Products

In 2006, Arkema inaugurated Europe's first plant capable of producing some 20 tonnes per year of multiwall carbon nanotubes, and has built a broad product portfolio for the polymer industry to include the elastomeric, thermoplastic, thermosetting, coating and adhesive sectors.

Hubron will offer the full Graphistrength® product range from its UK warehouses. The range currently includes the pure Graphistrength® products, and the extended range of masterbatches designed to ease incorporation into a whole range of elastomers, thermoplastics, resins and waterborne applications.

Commenting on the recent appointment, Jean-Marc Corpart, Graphistrength® Global Business Manager, said: “We are delighted to formalise our arrangements with Hubron, who have worked very closely with us over the last 2 years as we have brought products to the market. We are set to see real growth with these commercially exciting new products.”

Full details on the Graphistrength® range can be viewed on the dedicated Arkema website www.graphistrength.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Arkema. (2019, February 14). Arkema Appoints Hubron as Distributor of Graphistrength Multiwall Carbon Nanotube Products. AZoNano. Retrieved on December 03, 2024 from https://www.azonano.com/news.aspx?newsID=10274.

  • MLA

    Arkema. "Arkema Appoints Hubron as Distributor of Graphistrength Multiwall Carbon Nanotube Products". AZoNano. 03 December 2024. <https://www.azonano.com/news.aspx?newsID=10274>.

  • Chicago

    Arkema. "Arkema Appoints Hubron as Distributor of Graphistrength Multiwall Carbon Nanotube Products". AZoNano. https://www.azonano.com/news.aspx?newsID=10274. (accessed December 03, 2024).

  • Harvard

    Arkema. 2019. Arkema Appoints Hubron as Distributor of Graphistrength Multiwall Carbon Nanotube Products. AZoNano, viewed 03 December 2024, https://www.azonano.com/news.aspx?newsID=10274.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.